0001209191-20-046161.txt : 20200811
0001209191-20-046161.hdr.sgml : 20200811
20200811170247
ACCESSION NUMBER: 0001209191-20-046161
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200807
FILED AS OF DATE: 20200811
DATE AS OF CHANGE: 20200811
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRASSO MARC
CENTRAL INDEX KEY: 0001748894
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 201093188
MAIL ADDRESS:
STREET 1: C/O KURA ONCOLOGY, INC.
STREET 2: 3033 SCIENCE PARK ROAD, SUITE 220
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-07
0
0001422143
Kura Oncology, Inc.
KURA
0001748894
GRASSO MARC
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
0
1
0
0
CFO, CBO
Common Stock
2020-08-07
4
M
0
7102
15.47
A
10000
D
Common Stock
2020-08-07
4
S
0
10000
20.00
D
0
D
Option to purchase common stock
15.47
2020-08-07
4
M
0
7102
0.00
D
2029-01-21
Common Stock
7102
132898
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2019.
Includes 2,898 shares acquired on May 20, 2019 pursuant to the Issuer's Employee Stock Purchase Plan.
This option vests in 48 equal monthly installments commencing on January 22, 2019.
James Basta, Attorney-in-fact for Marc Grasso
2020-08-11